November 30, 2021. We congratulate our client, HIVE Blockchain Technologies Ltd (“HIVE”) (TSX.V:HIVE) (Nasdaq:HIVE) (FSE:HBF) on closing a Cnd$100,020,000 private placement of shares and warrants. Stifel GMP acted as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters including BMO Capital Markets, Canaccord Genuity Corp. and PI Financial Corp.
HIVE’s Executive Chairman, Frank Holmes, commented that, “These funds will allow us to HODL our Bitcoin and Ether supply while expanding our production to 3 Exahash in the early part of 2022. Also important was BMO’s participation, making it the first major Canadian bank to participate in a crypto data center equity financing.”
December 1, 2021. Again we congratulate HIVE on its investment in Titan.IO. Titan describes itself as offering software which helps Bitcoin miners increase their efficiency and scalability at a flat, low cost. It also operates the Titan Mining Pool, which recently surpassed 3 Exahash of Bitcoin mining capacity. Titan has also announced a disruptive decentralized hashpower routing protocol named Lumerin. The open source Lumerin Protocol is a peer-to-peer solution that enables the exchange of hashpower through smart contracts, making crypto mining hashpower tradable and liquid. The Lumerin Protocol will allow companies and individuals to buy, sell, and deliver hashpower, achieving decentralization through free market dynamics. The Lumerin Protocol is projected to make Bitcoin hashpower a tradable, liquid financial asset, unlocking mining profitability and providing greater access to capital and hedging strategies.
Hive’s Executive Chairman, Frank Holmes, described the team at Titan as “an extremely strong technological team.” He went on to say that “HIVE wants to participate in growth in the blockchain ecosystem such as mining software, transparent pools and innovative new tokens, and this is another strategic way to do that. We look forward to working with Titan to capture new opportunities as Bitcoin mining power shifts from China to North America.”
The Firm acts as U.S. counsel to HIVE.